GZMO Message Board - Msg: 7729368

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GZMO

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (25)	2/9/1999 1:01:00 AM
From: margie	of 438

This past weekend Baron's reported that Mills Value Adviser purchased an additional 140,618 shares of enmd at $25.26 to $29.97 between 1/11 to 1/27. They now have a 7.3% stake, up from 6.1% in January. I'm sure they are real happy. Interesting news about the "mystery" protein and quite a coup for gzmo, the new oncology division of Genzyme.....sigh As usual, Richard, looks like you're right about enmd.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next